Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Protalix BioTherapeutics to Present at the Piper Jaffray 20th Annual Health Care Conference
Nov 25, 2008 08:04 AM
- Protalix BioTherapeutics to Present at Oppenheimer Annual Healthcare Conference and at Barclays Capital Small & Mid-Cap Health Care Conference
Oct 28, 2008 07:34 AM
- Protalix BioTherapeutics Provides Enrollment Update for the Phase III Clinical Trial of prGCD
Sep 22, 2008 07:32 AM
- Protalix BioTherapeutics to Present at the UBS Global Life Sciences Conference
Sep 17, 2008 04:01 PM
- Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
Sep 08, 2008 04:00 PM
- Protalix BioTherapeutics to Present at the Oppenheimer Small and Mid Cap Clinical and Regulatory Conference
Jul 31, 2008 12:19 PM
- Protalix BioTherapeutics Joins the Russell Microcap(TM) Index
Jul 01, 2008 07:33 AM
- Protalix BioTherapeutics to Initiate an Open-Label Extension Study for the Phase III Clinical Trial of prGCD
Jun 03, 2008 08:43 AM
- Protalix BioTherapeutics to Present at Three International Healthcare Conferences
May 23, 2008 12:33 PM
- Protalix BioTherapeutics Receives Research Grant from the Office of the Chief Scientist of Israel's Ministry of Industry and Trade
Apr 08, 2008 08:28 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
PLX
|
Compare to S&P
|
| YTD |
-64.71 %
|
-42.18 %
|
| 4 Weeks |
-29.41 %
|
-23.70 %
|
| 12 Weeks |
-46.19 %
|
-25.41 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 25.00 %
|
|
EPS Growth in Last Year: -28.57 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
